Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma
Article 2021 en
Authors
PF
Petros Fessas
MN
Muntaha Naeem
MP
Matthias Pinter
Abstract
1 min read
Unlike other oncological indications, ATB in the 30 days before or after ICI initiation is associated with improved benefit from immunotherapy, independent of disease and treatment-related features. Evaluation of the immune microbiologic determinants of response to ICI in HCC warrants further investigation.
Ciro Celsa, Giuseppe Cabibbo, Thomas U. Marron, Anwaar Saeed, Matthias Pinter, Yi‐Hsiang Huang, A. Pillai, Martin Schoenlein, Johann von Felden, Peter R. Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G. Singal, Hong Jae Chon, Wei‐Fan Hsu, Leonardo Brunetti, Carmine Pinto, Melissa Bersanelli, Alessio Cortellini, D.J. Pinato
Yulei Wang, Yinghui Guan, Alexander R. Abbas, Yuji Sano, Susan Jain, Shan Lu, Habib Hamidi, Hartmut Koeppen, Yumiko Azuma, Yoko Kayukawa, Junko Shinozuka, Alekhya Pochiraju, Joshua D. Webster, Natascha Rieder, Gabriele Dietmann, Michael A. Cannarile, Christopher Cotter, Stephen P. Hack, Edward Cha, Takahiro Ishiguro, Josep M. Llovet, Andrew X. Zhu, Richard S. Finn
Discussion(0)
No comments yet. Be the first to comment.